Financhill
Sell
39

CPB Quote, Financials, Valuation and Earnings

Last price:
$28.56
Seasonality move :
1.27%
Day range:
$28.33 - $28.77
52-week range:
$27.85 - $43.85
Dividend yield:
5.46%
P/E ratio:
14.78x
P/S ratio:
0.84x
P/B ratio:
2.15x
Volume:
12.3M
Avg. volume:
7.3M
1-year change:
-31.27%
Market cap:
$8.5B
Revenue:
$10.3B
EPS (TTM):
$1.93
Period Ending 2021-07-31 2022-07-31 2023-07-31 2024-07-31 2025-07-31
Revenue $8.5B $8.6B $9.4B $9.6B $10.3B
Revenue Growth (YoY) -2.47% 1.02% 9.29% 2.98% 6.4%
 
Cost of Revenues $5.8B $6B $6.5B $6.7B $7.2B
Gross Profit $2.7B $2.6B $2.9B $2.9B $3.1B
Gross Profit Margin 32.01% 30.22% 30.92% 30.51% 29.91%
 
R&D Expenses $84M $87M $89M $99M $97M
Selling, General & Admin $1.4B $1.4B $1.5B $1.6B $1.6B
Other Inc / (Exp) $275M $15M -$13M -$226M --
Operating Expenses $1.5B $1.4B $1.5B $1.6B $1.7B
Operating Income $1.2B $1.2B $1.4B $1.3B $1.4B
 
Net Interest Expenses $209M $188M $187M $247M $342M
EBT. Incl. Unusual Items $1.3B $975M $1.1B $757M $796M
Earnings of Discontinued Ops. -$6M -- -- -- --
Income Tax Expense $328M $218M $270M $190M $194M
Net Income to Company $1B $757M $858M $567M $602M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1B $757M $858M $567M $602M
 
Basic EPS (Cont. Ops) $3.31 $2.51 $2.87 $1.90 $2.02
Diluted EPS (Cont. Ops) $3.29 $2.51 $2.85 $1.89 $2.01
Weighted Average Basic Share $303M $301M $299M $298M $298M
Weighted Average Diluted Share $305M $302M $301M $300M $300M
 
EBITDA $1.6B $1.5B $1.8B $1.7B $1.8B
EBIT $1.2B $1.2B $1.4B $1.3B $1.4B
 
Revenue (Reported) $8.5B $8.6B $9.4B $9.6B $10.3B
Operating Income (Reported) $1.2B $1.2B $1.4B $1.3B $1.4B
Operating Income (Adjusted) $1.2B $1.2B $1.4B $1.3B $1.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $2.2B $2.6B $2.5B $2.8B $2.7B
Revenue Growth (YoY) -4.44% 15.16% -2.21% 10.09% -3.43%
 
Cost of Revenues $1.5B $1.8B $1.7B $1.9B $1.9B
Gross Profit $704M $806M $785M $859M $783M
Gross Profit Margin 31.49% 31.3% 31.18% 30.99% 29.25%
 
R&D Expenses $21M $21M $23M $25M $24M
Selling, General & Admin $326M $359M $380M $425M $420M
Other Inc / (Exp) $12M -$15M -$9M -$29M --
Operating Expenses $346M $375M $392M $441M $442M
Operating Income $358M $431M $393M $418M $341M
 
Net Interest Expenses $47M $47M $49M $86M $81M
EBT. Incl. Unusual Items $329M $390M $310M $284M $256M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $68M $93M $76M $66M $62M
Net Income to Company $261M $297M $234M $218M $194M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $261M $297M $234M $218M $194M
 
Basic EPS (Cont. Ops) $0.86 $0.99 $0.79 $0.73 $0.65
Diluted EPS (Cont. Ops) $0.86 $0.99 $0.78 $0.72 $0.65
Weighted Average Basic Share $302M $299M $298M $298M $298M
Weighted Average Diluted Share $303M $301M $299M $301M $299M
 
EBITDA $441M $522M $489M $527M $440M
EBIT $358M $431M $393M $418M $341M
 
Revenue (Reported) $2.2B $2.6B $2.5B $2.8B $2.7B
Operating Income (Reported) $358M $431M $393M $418M $341M
Operating Income (Adjusted) $358M $431M $393M $418M $341M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $8.4B $8.9B $9.3B $9.9B $10.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.8B $6.3B $6.4B $6.9B $7.1B
Gross Profit $2.6B $2.7B $2.9B $3B $3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $85M $87M $91M $101M $96M
Selling, General & Admin $1.4B $1.4B $1.5B $1.6B $1.6B
Other Inc / (Exp) $260M -$12M -$27M -$246M --
Operating Expenses $1.5B $1.4B $1.5B $1.7B $1.7B
Operating Income $1.2B $1.2B $1.3B $1.3B $1.4B
 
Net Interest Expenses $202M $189M $189M $284M $337M
EBT. Incl. Unusual Items $1.3B $1B $1B $731M $768M
Earnings of Discontinued Ops. -$6M -- -- -- --
Income Tax Expense $299M $243M $253M $180M $190M
Net Income to Company $954M $793M $795M $551M $578M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $960M $793M $795M $551M $578M
 
Basic EPS (Cont. Ops) $3.15 $2.64 $2.66 $1.85 $1.94
Diluted EPS (Cont. Ops) $3.14 $2.63 $2.65 $1.84 $1.93
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $1.5B $1.6B $1.7B $1.8B $1.8B
EBIT $1.2B $1.2B $1.3B $1.3B $1.4B
 
Revenue (Reported) $8.4B $8.9B $9.3B $9.9B $10.2B
Operating Income (Reported) $1.2B $1.2B $1.3B $1.3B $1.4B
Operating Income (Adjusted) $1.2B $1.2B $1.3B $1.3B $1.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $2.2B $2.6B $2.5B $2.8B $2.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5B $1.8B $1.7B $1.9B $1.9B
Gross Profit $704M $806M $785M $859M $783M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $21M $21M $23M $25M $24M
Selling, General & Admin $326M $359M $380M $425M $420M
Other Inc / (Exp) $12M -$15M -$9M -$29M --
Operating Expenses $346M $375M $392M $441M $442M
Operating Income $358M $431M $393M $418M $341M
 
Net Interest Expenses $47M $47M $49M $86M $81M
EBT. Incl. Unusual Items $329M $390M $310M $284M $256M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $68M $93M $76M $66M $62M
Net Income to Company $261M $297M $234M $218M $194M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $261M $297M $234M $218M $194M
 
Basic EPS (Cont. Ops) $0.86 $0.99 $0.79 $0.73 $0.65
Diluted EPS (Cont. Ops) $0.86 $0.99 $0.78 $0.72 $0.65
Weighted Average Basic Share $302M $299M $298M $298M $298M
Weighted Average Diluted Share $303M $301M $299M $301M $299M
 
EBITDA $441M $522M $489M $527M $440M
EBIT $358M $431M $393M $418M $341M
 
Revenue (Reported) $2.2B $2.6B $2.5B $2.8B $2.7B
Operating Income (Reported) $358M $431M $393M $418M $341M
Operating Income (Adjusted) $358M $431M $393M $418M $341M
Period Ending 2021-07-31 2022-07-31 2023-07-31 2024-07-31 2025-07-31
Cash and Equivalents $69M $109M $189M $108M $132M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $544M $490M $494M $587M $541M
Inventory $933M $1.2B $1.3B $1.4B $1.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $98M $67M $52M $66M --
Total Current Assets $1.7B $2B $2.1B $2.2B $2.2B
 
Property Plant And Equipment $2.6B $2.6B $2.7B $3B $3.1B
Long-Term Investments -- -- -- -- $5M
Goodwill $4B $4B $4B $5.1B --
Other Intangibles $3.2B $3.2B $3.1B $4.7B --
Other Long-Term Assets $24M $24M $53M $78M --
Total Assets $11.7B $11.9B $12.1B $15.2B $14.9B
 
Accounts Payable $1.1B $1.3B $1.3B $1.3B $1.3B
Accrued Expenses $316M $309M $294M $402M --
Current Portion Of Long-Term Debt -- $565M -- $1.1B --
Current Portion Of Capital Lease Obligations $65M $76M $83M $115M --
Other Current Liabilities $3M $34M $6M $16M --
Total Current Liabilities $1.8B $2.9B $2.2B $3.6B $2.9B
 
Long-Term Debt $5.2B $4.2B $4.7B $6B $6.4B
Capital Leases -- -- -- -- --
Total Liabilities $8.6B $8.6B $8.4B $11.4B $11B
 
Common Stock $12M $12M $12M $12M $12M
Other Common Equity Adj $5M $2M -$3M -$17M --
Common Equity $3.2B $3.3B $3.7B $3.8B $3.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2M $2M $2M $2M $2M
Total Equity $3.2B $3.3B $3.7B $3.8B $3.9B
 
Total Liabilities and Equity $11.7B $11.9B $12.1B $15.2B $14.9B
Cash and Short Terms $69M $109M $189M $108M $132M
Total Debt $5.2B $4.8B $4.7B $6.1B $6.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Cash and Equivalents $69M $130M $91M $808M $168M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $731M $733M $726M $840M $768M
Inventory $974M $1.4B $1.3B $1.4B $1.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $102M $80M $82M $76M --
Total Current Assets $1.9B $2.3B $2.2B $3.1B $2.6B
 
Property Plant And Equipment $2.6B $2.5B $2.7B $3B $3.1B
Long-Term Investments -- -- $3M -- --
Goodwill $4B $4B $4B $5.1B --
Other Intangibles $3.2B $3.2B $3.1B $4.7B --
Other Long-Term Assets $458M $401M $504M $566M --
Total Assets $11.9B $12.2B $12.3B $16.1B $15.2B
 
Accounts Payable $1.2B $1.4B $1.4B $1.5B $1.5B
Accrued Expenses $539M $534M $541M $622M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.3B $3B $2.3B $3.5B $3.1B
 
Long-Term Debt $4.7B $4.2B $4.7B $7B $6.3B
Capital Leases -- -- -- -- --
Total Liabilities $8.7B $8.7B $8.5B $12.3B $11.2B
 
Common Stock $12M $12M $12M $12M $12M
Other Common Equity Adj $7M -$4M -$6M -$13M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2M $2M $2M $2M $2M
Total Equity $3.2B $3.5B $3.8B $3.8B $4B
 
Total Liabilities and Equity $11.9B $12.2B $12.3B $16.1B $15.2B
Cash and Short Terms $69M $130M $91M $808M $168M
Total Debt $5.2B $5B $4.7B $7B $6.4B
Period Ending 2021-07-31 2022-07-31 2023-07-31 2024-07-31 2025-07-31
Net Income to Stockholders $1B $757M $858M $567M $602M
Depreciation & Amoritzation $317M $337M $387M $411M $434M
Stock-Based Compensation $64M $59M $63M $99M $57M
Change in Accounts Receivable -$20M $48M -$1M -$16M $26M
Change in Inventories -$77M -$314M -$64M $11M -$80M
Cash From Operations $1B $1.2B $1.1B $1.2B $1.1B
 
Capital Expenditures $275M $242M $370M $517M $426M
Cash Acquisitions $2M $1M $13M $2.6B $144M
Cash From Investing -$158M -$230M -$340M -$3.1B -$187M
 
Dividends Paid (Ex Special Dividend) $439M $451M $447M $445M $459M
Special Dividend Paid
Long-Term Debt Issued $320M $1.2B $4.2B $8.1B --
Long-Term Debt Repaid -$1.5B -$997M -$4.3B -$5.7B --
Repurchase of Common Stock $36M $167M $142M $67M $62M
Other Financing Activities -$15M -$471M -$18M -$69M --
Cash From Financing -$1.7B -$910M -$723M $1.9B -$919M
 
Beginning Cash (CF) $69M $109M $189M $108M $132M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$790M $40M $80M -$81M $24M
Ending Cash (CF) -$719M $148M $269M $26M $155M
 
Levered Free Cash Flow $760M $939M $773M $668M $705M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $261M $297M $234M $218M $194M
Depreciation & Amoritzation $83M $91M $96M $109M $99M
Stock-Based Compensation $14M $15M $17M $19M $13M
Change in Accounts Receivable -$137M -$198M -$207M -$211M -$191M
Change in Inventories -$40M -$118M -$52M -$62M -$83M
Cash From Operations $288M $227M $174M $225M $224M
 
Capital Expenditures $69M $77M $143M $110M $127M
Cash Acquisitions -- $1M $4M $31M $56M
Cash From Investing -$68M -$78M -$137M -$47M -$137M
 
Dividends Paid (Ex Special Dividend) $116M $115M $114M $116M $120M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $371M $557M $1.1B $1.8B --
Long-Term Debt Repaid -$395M -$512M -$1.1B -$1.1B --
Repurchase of Common Stock $63M $41M $28M $54M $24M
Other Financing Activities -$18M -$18M -$15M -$36M --
Cash From Financing -$220M -$127M -$135M $523M -$51M
 
Beginning Cash (CF) $69M $130M $91M $808M $168M
Foreign Exchange Rate Adjustment -- -$1M -- -$1M --
Additions / Reductions -- $21M -$98M $700M $36M
Ending Cash (CF) $69M $150M -$7M $1.5B $204M
 
Levered Free Cash Flow $219M $150M $31M $115M $97M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $954M $793M $795M $551M $578M
Depreciation & Amoritzation $324M $345M $392M $424M $424M
Stock-Based Compensation $62M $60M $65M $101M $51M
Change in Accounts Receivable $32M -$13M -$10M -$20M $46M
Change in Inventories -$79M -$392M $2M $1M -$101M
Cash From Operations $1.1B $1.1B $1.1B $1.2B $1.1B
 
Capital Expenditures $270M $250M $436M $484M $443M
Cash Acquisitions $1M $2M $16M $2.7B $169M
Cash From Investing -$154M -$240M -$399M -$3B -$277M
 
Dividends Paid (Ex Special Dividend) $447M $450M $446M $447M $463M
Special Dividend Paid
Long-Term Debt Issued $691M $1.4B $4.7B $8.8B --
Long-Term Debt Repaid -$1.8B -$1.1B -$4.9B -$5.7B --
Repurchase of Common Stock $99M $145M $129M $93M $32M
Other Financing Activities -$19M -$471M -$15M -$90M --
Cash From Financing -$1.6B -$817M -$731M $2.5B -$1.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$653M $61M -$39M $717M -$640M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $873M $870M $654M $752M $687M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $261M $297M $234M $218M $194M
Depreciation & Amoritzation $83M $91M $96M $109M $99M
Stock-Based Compensation $14M $15M $17M $19M $13M
Change in Accounts Receivable -$137M -$198M -$207M -$211M -$191M
Change in Inventories -$40M -$118M -$52M -$62M -$83M
Cash From Operations $288M $227M $174M $225M $224M
 
Capital Expenditures $69M $77M $143M $110M $127M
Cash Acquisitions -- $1M $4M $31M $56M
Cash From Investing -$68M -$78M -$137M -$47M -$137M
 
Dividends Paid (Ex Special Dividend) $116M $115M $114M $116M $120M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $371M $557M $1.1B $1.8B --
Long-Term Debt Repaid -$395M -$512M -$1.1B -$1.1B --
Repurchase of Common Stock $63M $41M $28M $54M $24M
Other Financing Activities -$18M -$18M -$15M -$36M --
Cash From Financing -$220M -$127M -$135M $523M -$51M
 
Beginning Cash (CF) $69M $130M $91M $808M $168M
Foreign Exchange Rate Adjustment -- -$1M -- -$1M --
Additions / Reductions -- $21M -$98M $700M $36M
Ending Cash (CF) $69M $150M -$7M $1.5B $204M
 
Levered Free Cash Flow $219M $150M $31M $115M $97M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 22

Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.

Buy
54
BMRN alert for Dec 22

BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.

Buy
82
RKLB alert for Dec 22

Rocket Lab Corp. [RKLB] is up 9.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock